CHRISTINA LAYTON: Open Payments
NPI 1649868027 · OVERLAND PARK, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$545 in 24 payments from 11 companies in 2025. Trend: 2023 $412 · 2024 $427 · 2025 $545
Food & beverage: $545
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 5 | $122 |
| ABBVIE INC. | 3 | $67 |
| Otsuka America Pharmaceutical, Inc. | 3 | $63 |
| Neurocrine BioSciences, Inc. | 2 | $51 |
| Edwards Lifesciences Corporation | 1 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $41 |
| Axsome Therapeutics, Inc. | 2 | $39 |
| E.R. Squibb & Sons, L.L.C. | 2 | $37 |
| Noven Therapeutics, LLC | 2 | $34 |
| Biogen, Inc. | 1 | $28 |
Products named: SPRAVATO, VRAYLAR, ABILIFY ASIMTUFII, INGREZZA, SAPIEN 3 Ultra RESILIA, TRINTELLIX, Auvelity, COBENFY.
Industry payments across KS — which companies pay providers there.
